GC68783
BMS-820132
Also known as 3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-N-[1-(diethoxyphosphorylmethyl)pyrazol-3-yl]-5-propan-2-yloxybenzamide
BMS-820132 is an orally effective, partial glucokinase activator with an AC50 of 29 nM· It can lower glucose levels in normal rat oral glucose tolerance test (OGTT) models but does not reduce glucose levels in Zucker diabetic fatty (ZDF) rats· BMS-820132 has pharmacological toxicity secondary to potent GK activation
ChemicalCAS1001419-18-6MW572.55FormulaC26H33N6O7P
- CAS number
- 1001419-18-6
- Molecular weight
- 572.55
- Formula
- C26H33N6O7P
- Solubility
- DMSO ： 25 mg/mL (43·66 mM; Need ultrasonic)
- InChIKey
- OYUDYQMFVRHPIY-UHFFFAOYSA-N
- Catalogue number
- GC68783
- Brand
- GLPBIO
Computed properties PubChem CID 58265877 · XLogP 1.8 · TPSA 147 Ų · H-bond donors 1
- XLogP
- 1.8
- TPSA
- 147 Ų
- H-bond donors
- 1
- H-bond acceptors
- 10
- Rotatable bonds
- 13
- Heavy atoms
- 40
SMILES CCOP(=O)(CN1C=CC(=N1)NC(=O)C2=CC(=CC(=C2)OC(C)C)OC3=NC=C(N=C3)C(=O)N4CCC4)OCC
Computed descriptors from PubChem (CID 58265877), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il